Abstract
The inhibition and stimulation of short-circuit current in in vitro frog skin by a series of structural analogs of the diuretic drug amiloride were studied. Also, the inhibitory profile of a new experimental diuretic, 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine, or CGS 4270, was determined. The major conclusions of our studies are: 1) amiloride remains the most effective inhibitor of Na+ entry, with both the pyrazine ring and the acylguanidine moiety being required for maximum activity; 2) CGS 4270 also inhibits Na+ transport in frog skin; it acts only from the external solution, is uncharged, is noncompetitive with Na+ and interacts noncompetitively with amiloride; the inhibition is independent of external calcium; and 3) benzimidazole increases amiloride-sensitive short-circuit current and this compound is competitive with amiloride. These results indicate that the putative Na+ entry protein contains multiple inhibitory sites and that compounds which stimulate Na+ entry may also bind at the same molecular locus as an inhibitor.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|